𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters

✍ Scribed by Barbara Suligoi; Maria Dorrucci; Ilaria Uccella; Massimo Andreoni; Giovanni Rezza


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
77 KB
Volume
69
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The effects of herpesviruses infection on the progression of HIV disease remain controversial, with some studies showing accelerated progression and others showing no effect. Furthermore, the effect of concurrent infection with more than one herpesvirus on the progression of HIV disease has never been investigated. To this end, the rates of progression of HIV disease were determined after stratifying for the presence of up to five different herpesvirus infections. The study population consisted of 359 HIV‐infected persons for whom the date of seroconversion was estimated (part of the Italian Seroconversion Study). One serum sample from each participant was tested for antibodies to five herpesviruses: HSV‐2, CMV, HHV‐6, HHV‐7, and HHV‐8. Univariate analysis showed that HSV‐2 and HHV‐8 were significantly associated with progression to AIDS, yet when adjusting for age at HIV seroconversion and for the presence of the other herpesvirus infections, only HHV‐8 infection showed a significant association. The age‐adjusted risk of progression to AIDS with Kaposi's sarcoma increased with the number of herpesvirus infections and was significant in individuals with four infections. The risk of progression to AIDS without Kaposi's sarcoma also increased with the number of infections, although not significantly. Similar results were found when considering CD4^+^ cell count <200 × 10^6^ cells/L as the endpoint. Concurrent infection with more than one herpesvirus does not appear to have a significant effect on the course of HIV disease, except for the known association between HHV‐8 and Kaposi's sarcoma. However, even after excluding Kaposi's sarcoma from the AIDS‐defining endpoints, a slightly increased risk for participants with four herpesvirus infections remained. J. Med. Virol. 69:182–187, 2003. Β© 2003 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Adverse effect of the CCR5 promoter βˆ’245
✍ Troels B. Knudsen; Thomas B. Kristiansen; Terese L. Katzenstein; Jesper Eugen-Ol πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 96 KB

## Abstract HIV positive individuals heterozygous for a 32 basepair deletion in the CCR5 encoding gene (CCR5 Ξ”32) have a reduced number of CCR5 receptors on the cell surface and a slower progression towards AIDS and death. Other human polymorphisms, such as the CCR2 64I and the CCR5 promoter βˆ’2459

Effect of the HIV-1 syncytium-inducing p
✍ Fitzgibbon, Joseph E.; Gaur, Sunanda; Gavai, Medha; Gregory, Patrice; Frenkel, L πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 2 views

The syncytium-inducing (SI) capability of HIV-1 isolates from 48 HIV-infected children was determined in order to examine the association of the SI phenotype with an AIDS diagnosis and/or with other clinical parameters in HIV-infected children. In a retrospective cross-sectional analysis, phenotypic

Cancer incidence in a cohort of human im
✍ Diego Serraino; Patrizio Pezzotti; Maria Dorrucci; Maria Barbara Alliegro; Aless πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 3 views

## Background: In addition to kaposi's sarcoma and non-hodgkin's lymphomas, it has been postulated that human immunodeficiency virus (hiv) infection may increase the risk of other cancers. the aim of the current study was to compare incidence rates of cancer among individuals who seroconverted for

A Markov model for HIV disease progressi
✍ Odd O. Aalen; Vernon T. Farewell; Daniela de Angelis; Nicholas E. Day; O. NΓΆel G πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 206 KB πŸ‘ 2 views

Back-calculation is a widely used method to estimate HIV incidence rates, and is commonly based on times of AIDS diagnosis. Following up earlier work, we extend this method to also incorporate knowledge of times of HIV diagnosis (first positive test). This is achieved through the use of a Markov mod